Wird geladen...
The Balance between the Safety of Mother, Fetus, and Newborn Undergoing Cystic Fibrosis Transmembrane Conductance Regulator Treatments during Pregnancy
[Image: see text] The recent development of modulators of cystic fibrosis transmembrane conductance regulator (CFTR) has allowed the life expectancy of cystic fibrosis patients to increase substantially resulting in more women with cystic fibrosis reaching child-bearing age. This however raises the...
Gespeichert in:
| Veröffentlicht in: | ACS Pharmacol Transl Sci |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American
Chemical Society
2020
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7551705/ https://ncbi.nlm.nih.gov/pubmed/33073185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00098 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|